Mid-and Long-term Efficacy of Ergot Alkaloids in the Treatment of Salivation in Patients With Parkinson's Disease.
Clinical trial NCT06035913 · UNKNOWN
Trial details
- NCT number
- NCT06035913
- Sponsor
- Nanjing First Hospital, Nanjing Medical University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-01
- Primary completion
- 2024-06-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.